Antibiotics Misuse in Conjunctivitis, A Step towards the Post-Antibiotic Era!

Volume 5 - Issue 1

Mina Abdelmseih*

Received:May 23, 2020   Published:June 03, 2020

DOI: 10.32474/SCSOAJ.2020.05.000205

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Conjunctivitis (inflammation of the conjunctiva) is the most frequent ocular disease worldwide. Acute infective conjunctivitis is a very common disease in primary healthcare. It is usually a mild condition and serious complications are uncommon. Viral conjunctivitis occurs in 80% of all patients of acute conjunctivitis. Topical antibiotics do not prevent repeated attacks, and their use may confuse healthcare providers. Use of Antibiotics in bacterial Conjunctivitis: At least 60% of patients of acute bacterial conjunctivitis are self-limiting within 1 to 2 weeks ‘duration. Studies of treatment show that there is a high rate of clinical recovery without any treatment (65% within 2-5 days). Unnecessary usage of antibiotics increases dramatically antibiotic-resistance. Antibiotic resistance among ocular organisms could be a challenge to the ophthalmologists. Antibiotic-resistant infections are a significant socioeconomic burden to the health care system. The problem is Global, reflecting the overuse of these drugs worldwide and the failure of the pharmaceutical companies ‘ development of new antibiotic agents to resolve the threat. Coordinated efforts are essential in implementing new strategies, establishing research efforts and taking steps to resolve the crisis new medications alone, will not be adequate to overcome the risk of antimicrobial resistance. Thus, WHO works with a lot of Nations to organize Infection control management plans.

Keywords: Conjunctivitis, Acute infective Conjunctivitis, bacterial conjunctivitis, viral conjunctivitis, Antibiotics, Antibiotic resistance, GPs, Healthcare system

Abstract| Introduction| Differential Diagnosis| References|